Bionano Genomics (BNGO) Depreciation and Depletion (2024 - 2026)

Bionano Genomics (BNGO) has 3 years of Depreciation and Depletion data on file, last reported at $1.0 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion fell 9.09% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (down 1.54% YoY), and the FY2025 full-year result was $4.2 million, down 14.29% from the prior year.
• Depreciation and Depletion improved to $1.0 million in Q1 2026, from -$1.1 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $5.4 million in Q4 2024 to a low of -$1.1 million in Q2 2025.
• A 3-year average of $1.2 million and a median of $1.0 million in 2026 frame the typical range for Depreciation and Depletion.
• Across the five-year window, Depreciation and Depletion soared 320.0% in 2025 and decreased 9.09% in 2026, its largest moves.
• Tracing BNGO's Depreciation and Depletion over 3 years: stood at $5.4 million in 2024, then sank by 120.37% to -$1.1 million in 2025, then surged by 190.91% to $1.0 million in 2026.
• Business Quant data shows BNGO's Depreciation and Depletion at $1.0 million in Q1 2026, -$1.1 million in Q2 2025, and $1.1 million in Q1 2025.